STROK@LLIANCE

Discover the latest resources from Etap-LAB

Contact an expert

Published on the 8 February 2025

POSTER: “Translational Relevance and Versatility of the Thromboembolic Stroke Model in Mice: Implications for Pharmacological and Safety Evaluations”

Dr Annelise LETOURNEUR, Director of Operations at STROK@LLIANCE and Neuroscience Study Director, presented the team's research* during the American Heart Association’s annual International Stroke Conf…
Published on the 17 May 2022

Preclinical models of cerebral haemorrhage

Haemorrhagic strokes account for 10-15% of all strokes. In 40% of patients, haemorrhagic strokes are fatal within one month, rising to 54% after 1 year. Haemorrhagic strokes have a devastating effect …
Published on the 1 March 2021

Newsletter #7: From bench to bed side: how the new preclinical stroke models change the game.

Strokes are the second most common cause of mortality in the over-60s and the leading cause of acquired disability. There are currently only two approved treatments for the management of patients affe…
Published on the 7 October 2019

Newsletter #6 – Modeling diversity in preclinical stroke

Taking clinical heterogeneity into account to increase the translational value of our preclinical models: the new STROK@LLIANCE research project Early in 2019, we announced the launch of a collabor…
Published on the 16 May 2019

Strok@lliance – Newsletter #5

Newsletter #5 Topics: I) Strok@lliance’s scientific conference will be held every two years: see you in spring 2020!II) European Stroke Action Plan 2018–2030: What about preclinical science?III…
Published on the 4 October 2018

Strok@lliance – Newsletter #4

Post-stroke deficits and recovery from bench to patient’s bed This year again, Strok@lliance aimed at bridging the gap between laboratory and clinical practices. The event occured at…
Published on the 22 May 2018

Strok@lliance – Newsletter #2

2nd Strok@lliance Annual Meeting June 5th, 2018 – 10:00 AM – 4:30 PMMAISON DE LA CHIMIE28 Rue Saint-Dominique, 75007 Parishttp://congres.maisondelachimie.com/ Post-stroke deficits and re…
Published on the 27 February 2018

Strok@lliance – Newsletter #1

Focus on an innovative model of thromboembolic stroke reproducing the clinical situation Recombinant tissue-type plasminogen activator (rt-PA) is the only approved drug treatment at the acute p…